CHR’s Medical Director, Dr. Norbert Gleicher, recently appeared on the Dr. Steve TV show on New York’s Channel 11 (also syndicated all over the country) to discuss why gender selection (sex selection) is increasing in popularity.
In his conversation with Dr. Steve, Dr. Gleicher summarized how a baby’s sex can be reliably selected, utilizing in vitro fertilization (IVF) and preimplantation genetic diagnosis (PGD). Like in routine infertility treatments, IVF is used to produce embryos. Each embryo is then examined for its chromosomal make up, using PGD gender selection, before being placed into the uterus of the patient. PGD reveals whether an embryo is female or male. Only the embryos of the desired sex are then transferred into the uterus.
“The method is about 99-plus percent accurate in determining the desired gender, and is by far the most accurate method for gender selection,” said Dr. Gleicher during the interview. “Nothing else even comes close.”
Dr. Gleicher also addressed potential safety and complex ethical issues regarding the use of PGD for gender selection, explaining how the procedure does not harm embryos, and the different medical reasons for which this procedure may be used in ethically responsible ways.
“For medical reasons gender selection has been around for more than 20 years. Gender selection is not only utilized because someone wakes up in the morning and says I want a boy or a girl,” explained Dr. Gleicher. He went on to describe how, for example, so-called sex-linked diseases, genetic diseases passed on only by mothers but expressed only by male offspring, can be prevented by choosing the sex of the baby with an IVF/PGD procedure.